Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01862510 · ClinicalTrials.gov registry record
Detection of Celiac Disease in Patients With Hypothyroidism
A clinical trial of Celiac Disease and Hypothyroidism, sponsored by University of Vermont.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01862510 is a study of Celiac Disease and Hypothyroidism that has completed, run by University of Vermont. The registered enrollment target is 500 participants, below the 1,959-participant average among 24 other Celiac Disease trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01862510, a study of Celiac Disease and Hypothyroidism, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with hypothyroidism that should prompt serologic testing for celiac disease.
Conditions Studied
Study Locations (1)
Vermont
- Fletcher Allen Health Care - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01862510
The ClinicalTrials.gov registry entry for NCT01862510 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,959-participant average among 24 other Celiac Disease trials with a reported enrollment target (74% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Celiac Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01862510 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT01862510 about?
NCT01862510 is a clinical study titled "Detection of Celiac Disease in Patients With Hypothyroidism". The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with ...
What is the current status of trial NCT01862510?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2012-03. Estimated completion is 2014-12.
What conditions does trial NCT01862510 study?
This clinical trial studies the following conditions: Celiac Disease, Hypothyroidism, Malabsorption, Celiac Sprue.
Who is sponsoring clinical trial NCT01862510?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01862510 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
-
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
RECRUITING · Phase 1
-
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RECRUITING
-
Immune Responses to Gluten
RECRUITING · NA
-
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.